Search

Your search keyword '"Ezquerra, E. A."' showing total 2 results
Start Over Author "Ezquerra, E. A." Topic hypertension
2 results on '"Ezquerra, E. A."'

1. [Impact of hypertension in cardiac diseases in Spain. The CARDIOTENS Study 1999].

Author

Juanatey JR, Ezquerra EA, Vidal JV, Caro JL, Acuña JG, and Maqueda IG

Subjects
Aged, Cross-Sectional Studies, Female, Heart Diseases etiology, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Spain, Heart Diseases epidemiology, Hypertension complications
Abstract

Introduction and Objectives: To analyze the prevalence and control of hypertensive patients with associated cardiac diseases in Spain., Methods: All the 32,051 outpatients seen the same day by 1,159 primary physicians (79%) and cardiologists (21%) were prospectively included in a database including history of cardiac disease (heart failure, coronary disease or atrial fibrillation), casual blood pressure and ongoing treatments., Results: Hypertension was present in 33% of the whole group and 19% had both hypertension and a cardiac disease. Hypertension was present in 77% of the patients with heart failure, in 66% of those with coronary diseases and in 66% with atrial fibrillation. Less than 60% of the hypertensive patients with heart failure were treated with an angiotensin or a converting enzyme inhibitor. Thirty-two percent of the hypertensive patients with coronary disease received a betablocker and 25% of the hypertensive patients with atrial fibrillation were on oral anticoagulation. Less than 20% of the patients with hypertension and cardiac disease had blood pressure levels under 130/85 mmHg as recommended by international guidelines. Patients seen by primary care physicians were found to be slightly better treated than those under cardiologists' care., Conclusions: High blood pressure is associated with heart failure, coronary disease and atrial fibrillation in a high percentage of patients. The blood pressure levels recommended by current guidelines for cardiac hypertensives were attained in less than 20% of the cases. The control of blood pressure in these high risk hypertensive patients was low and the use of appropriate pharmacological treatment was poor.

Published
2001
Full Text
View/download PDF

2. European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)

Author

Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., Deaton, C., Ebrahim, S., Fisher, M., Germano, G., Hobbs, R., Hoes, A., Karadeniz, S., Mezzani, A., Prescott, E., Ryden, L., Scherer, M., Syvanne, M., Scholte Op Reimer, W. J. M., Vrints, C., Wood, D., Zamorano, J. L., Zannad, F., Cooney, M. T., Bax, J., Baumgartner, H., Ceconi, C., Dean, V., Fagard, R., Funck Brentano, C., Hasdai, D., Kirchhof, P., Knuuti, J., Kolh, P., Mcdonagh, T., Moulin, C., Popescu, B. A., Sechtem, U., Sirnes, P. A., Tendera, M., Torbicki, A., Vahanian, A., Windecker, S., Aboyans, V., Ezquerra, E. A., Baigent, C., Brotons, C., Burell, G., Ceriello, A., De Sutter, J., Deckers, J., Del Prato, S., Diener, H. C., Fitzsimons, D., Fras, Z., Hambrecht, R., Jankowski, P., Keil, U., Kirby, M., Larsen, M. L., Mancia, G., Manolis, A. J., Mcmurray, J., Pajak, A., Parkhomenko, A., Rallidis, L., Rigo, F., Rocha, E., Ruilope, L. M., Van Der Velde, E., Vanuzzo, D., Viigimaa, M., Volpe, Massimo, Wiklund, O., Wolpert, C., Authors/task Force Members, Parts Of The Guidelines:, Other Experts Who Contributed T. O., Esc, Committee For Practice Guidelines :., Document, Reviewers, School of Health and Caring Sciences, Linnaeus University, Department of Public Health, University of Gent, University Hospital Center Zagreb, 2nd Department of Internal Medicine, Faculty of Epidemiology and Population Health [London], London School of Hygiene and Tropical Medicine (LSHTM), Primary Care Clinical Sciences, University of Birmingham [Birmingham], Service de Cardiologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Neuroépidémiologie Tropicale (NET), Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), and Université de Limoges (UNILIM)-Université de Limoges (UNILIM)-CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
Male, Epidemiology, medicine.medical_treatment, General Practice, physical activity, Blood Pressure, Smoking Prevention, Comorbidity, prevention, Electronic Health Records, Myocardial infarction, ComputingMilieux_MISCELLANEOUS, education.field_of_study, Rehabilitation, Cardiac Rehabilitation, Evidence-Based Medicine, Prognosis, Cardiovascular disease, Lipids, Drug Combinations, nutrition, Cardiovascular Diseases, Cardiology and Cardiovascular Medicine, Diagnostic Imaging, medicine.medical_specialty, Hypercholesterolemia, Advisory Committees, Health Promotion, Risk Assessment, Medication Adherence, European guidelines, cardiovascular disease prevention, Humans, education, Physician's Role, Exercise, Life Style, Aged, Primary Health Care, Patient Selection, Cardiovascular Agents, medicine.disease, Self Care, Health promotion, Early Diagnosis, Diabetes Mellitus, Type 2, Cardiology, Disease prevention, Risk Reduction Behavior, Biomarkers, Diabetic Angiopathies, Systolic hypertension, Risk Factors, Preventive Health Services, Applied Psychology, Middle Aged, Clopidogrel, Clinical Practice, Hospitalization, Europe, Treatment Outcome, Heart Function Tests, Hypertension, Female, Heart Protection Study, medicine.drug, Adult, Consensus, United Kingdom Prospective Diabetes Study, Population, MEDLINE, psychosocial factors, risk assessment, risk management, smoking, Nurse's Role, Predictive Value of Tests, Internal medicine, medicine, Obesity, cardiovascular diseases, Antihypertensive Agents, Task force, business.industry, Percutaneous coronary intervention, Diet, Socioeconomic Factors, Family medicine, Heart failure, Chronic Disease, Smoking Cessation, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, Delivery of Health Care, Stress, Psychological, Kidney disease
Abstract

ABI : ankle–brachial index ACCORD : Action to Control Cardiovascular Risk in Diabetes ADVANCE : Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation AGREE : Appraisal of Guidelines Research and Evaluation AHA : American Heart Association apoA1 : apolipoprotein A1 apoB : apolipoprotein B CABG : coronary artery bypass graft surgery CARDS : Collaborative AtoRvastatin Diabetes Study CCNAP : Council on Cardiovascular Nursing and Allied Professions CHARISMA : Clopidogrel for High Athero-thrombotic Risk and Ischemic Stabilisation, Management, and Avoidance CHD : coronary heart disease CKD : chronic kidney disease COMMIT : Clopidogrel and Metoprolol in Myocardial Infarction Trial CRP : C-reactive protein CURE : Clopidogrel in Unstable Angina to Prevent Recurrent Events CVD : cardiovascular disease DALYs : disability-adjusted life years DBP : diastolic blood pressure DCCT : Diabetes Control and Complications Trial ED : erectile dysfunction eGFR : estimated glomerular filtration rate EHN : European Heart Network EPIC : European Prospective Investigation into Cancer and Nutrition EUROASPIRE : European Action on Secondary and Primary Prevention through Intervention to Reduce Events GFR : glomerular filtration rate GOSPEL : Global Secondary Prevention Strategies to Limit Event Recurrence After MI GRADE : Grading of Recommendations Assessment, Development and Evaluation HbA1c : glycated haemoglobin HDL : high-density lipoprotein HF-ACTION : Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing HOT : Hypertension Optimal Treatment Study HPS : Heart Protection Study HR : hazard ratio hsCRP : high-sensitivity C-reactive protein HYVET : Hypertension in the Very Elderly Trial ICD : International Classification of Diseases IMT : intima-media thickness INVEST : International Verapamil SR/Trandolapril JTF : Joint Task Force LDL : low-density lipoprotein Lp(a) : lipoprotein(a) LpPLA2 : lipoprotein-associated phospholipase 2 LVH : left ventricular hypertrophy MATCH : Management of Atherothrombosis with Clopidogrel in High-risk Patients with Recent Transient Ischaemic Attack or Ischaemic Stroke MDRD : Modification of Diet in Renal Disease MET : metabolic equivalent MONICA : Multinational MONItoring of trends and determinants in CArdiovascular disease NICE : National Institute of Health and Clinical Excellence NRT : nicotine replacement therapy NSTEMI : non-ST elevation myocardial infarction ONTARGET : Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial OSA : obstructive sleep apnoea PAD : peripheral artery disease PCI : percutaneous coronary intervention PROactive : Prospective Pioglitazone Clinical Trial in Macrovascular Events PWV : pulse wave velocity QOF : Quality and Outcomes Framework RCT : randomized clinical trial RR : relative risk SBP : systolic blood pressure SCORE : Systematic Coronary Risk Evaluation Project SEARCH : Study of the Effectiveness of Additional Reductions in Cholesterol and SHEP : Systolic Hypertension in the Elderly Program STEMI : ST-elevation myocardial infarction SU.FOL.OM3 : SUpplementation with FOlate, vitamin B6 and B12 and/or OMega-3 fatty acids Syst-Eur : Systolic Hypertension in Europe TNT : Treating to New Targets UKPDS : United Kingdom Prospective Diabetes Study VADT : Veterans Affairs Diabetes Trial VALUE : Valsartan Antihypertensive Long-term Use VITATOPS : VITAmins TO Prevent Stroke VLDL : very low-density lipoprotein WHO : World Health Organization ### 1.1 Introduction Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously throughout life and usually progressing to an advanced stage by the time symptoms occur. It remains the major cause of premature death in Europe, even though CVD mortality has …

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results